![positive/negative impacts of globalization in austria positive/negative impacts of globalization in austria](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs41463-019-00057-7/MediaObjects/41463_2019_57_Fig1_HTML.png)
![positive/negative impacts of globalization in austria positive/negative impacts of globalization in austria](https://image.slidesharecdn.com/liberalisationprivatisationandglobalisation-130725021039-phpapp02/95/liberalisation-privatisation-and-globalisation-22-638.jpg)
Research has explored reasons for such variability. In contrast, the emergency contraceptive became prescription-free in Austria in 2009, six years before the usually less restrictive Germany, and approximately eight years after the United Kingdom (UK), and France. Nasal corticosteroids for allergy, triptans for migraine, antibiotic eye preparations for conjunctivitis, and dermal hydrocortisone for dermatitis exemplify medicines found to require a prescription in Austria but which have been reclassified elsewhere, in some cases at least 25 years ago. In a 16 country comparison, Austria was one of the most restrictive nations in the range of medicines requiring a prescription. International comparative research can provide valuable insights to balance benefits and risks. only through a pharmacy), label-warnings, pack size limitations, training for pharmacy staff, and screening tools have been developed to address potential risks. Strategies such as restrictions on availability (e.g. Potential downsides of reclassification include adverse events, misuse or abuse of medicines, reduced opportunistic screening, and delayed diagnosis of important conditions. However, reclassification also poses risks. smoking cessation and vaccination) and increase the time available to doctors to attend to serious medical needs. It could also help to address undertreatment of conditions, aid public health initiatives (e.g. It could save time for patients, save health resources, empower patients, and enable more timely treatment of conditions. The widened access to medicines from reclassification could benefit individuals, health funders and society. This development has taken place despite variability in reclassification between countries.
![positive/negative impacts of globalization in austria positive/negative impacts of globalization in austria](https://globalise-theenvironment.weebly.com/uploads/3/7/4/1/3741597/98907.jpg)
To facilitate self-care, reclassification (or switching) of medicines from prescription to non-prescription has been taking place internationally for decades. Increasing self-care offers a possible way to contain health care costs in Europe, a challenge which is likely to become even more important in managing the economic consequences of a Covid-19-related recession. This does not alter our adherence to PLOS ONE policies on sharing data and materials. IGEPHA funded the publication fee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.Ĭompeting interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: NG reports consultancy work on reclassification, and speaker and travel costs for IGEPHA CB is employed by AGES, the medicines regulator, but has no other conflicts to report SB has no conflicts to report.
![positive/negative impacts of globalization in austria positive/negative impacts of globalization in austria](http://2.bp.blogspot.com/-Z5zwhwB_tBU/UYrLKR3-LdI/AAAAAAAAACY/oEHc_TuHyJY/s640/negg.png)
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.ĭata Availability: Data is not available upon request due to ethical restrictions agreed with the University of Auckland human participants ethics committee and an undertaking to participants.įunding: IGEPHA (the Austrian Self-Care Association) funded the project, this included payment to the University of Auckland which then contracted NG to conduct the research. Received: JAccepted: DecemPublished: January 25, 2021Ĭopyright: © 2021 Gauld et al. PLoS ONE 16(1):Įditor: Katie MacLure, BCS Health & Care Scotland, UNITED KINGDOM Citation: Gauld NJ, Baumgärtel CA, Buetow SA (2021) Why are self-medication opportunities limited in Austria? An interview study and comparison with other countries.